155 related articles for article (PubMed ID: 1448779)
21. Characterisation of type 2N von Willebrand disease using phenotypic and molecular techniques.
Nesbitt IM; Goodeve AC; Guilliatt AM; Makris M; Preston FE; Peake IR
Thromb Haemost; 1996 Jun; 75(6):959-64. PubMed ID: 8822593
[TBL] [Abstract][Full Text] [Related]
22. Molecular study of VWF gene from Mexican Mestizo patients with von Willebrand disease, and the finding of three new mutations.
Melo-Nava BM; Benítez H; Palacios JJ; Nieva B; Arenas D; Jaloma-Cruz AR; Navarrete C; Salamanca F; Peñaloza R
Blood Cells Mol Dis; 2007; 39(3):361-5. PubMed ID: 17681836
[TBL] [Abstract][Full Text] [Related]
23. von Willebrand disease: a database of point mutations, insertions, and deletions. For the Consortium on von Willebrand Factor Mutations and Polymorphisms, and the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
Ginsburg D; Sadler JE
Thromb Haemost; 1993 Feb; 69(2):177-84. PubMed ID: 8456431
[TBL] [Abstract][Full Text] [Related]
24. Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease.
Gallinaro L; Sartorello F; Pontara E; Cattini MG; Bertomoro A; Bartoloni L; Pagnan A; Casonato A
Thromb Haemost; 2006 Dec; 96(6):711-6. PubMed ID: 17139363
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the genetic defects in recessive type 1 and type 3 von Willebrand disease patients of Italian origin.
Eikenboom JC; Castaman G; Vos HL; Bertina RM; Rodeghiero F
Thromb Haemost; 1998 Apr; 79(4):709-17. PubMed ID: 9569178
[TBL] [Abstract][Full Text] [Related]
26. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
Michiels JJ; Gadisseur A; Budde U; Berneman Z; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467
[TBL] [Abstract][Full Text] [Related]
27. Von Willebrand's disease: a novel mutation, P1824H and the incidence of R1205H defect among families with dominant quantitative von Willebrand factor deficiency.
Casaña P; Cabrera N; Haya S; Cid AR; Aznar JA
Haematologica; 2006 Aug; 91(8):1130-3. PubMed ID: 16870550
[TBL] [Abstract][Full Text] [Related]
28. The genetic defect of type I von Willebrand disease "Vicenza" is linked to the von Willebrand factor gene.
Randi AM; Sacchi E; Castaman GC; Rodeghiero F; Mannucci PM
Thromb Haemost; 1993 Feb; 69(2):173-6. PubMed ID: 8456430
[TBL] [Abstract][Full Text] [Related]
29. [Study on genetic mutations of the vWF in type 2A von Willebrand disease].
Wang Y; Zhang J; Zhang W; Cheng D; Wan H; Ruan C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Aug; 17(4):229-32. PubMed ID: 10932002
[TBL] [Abstract][Full Text] [Related]
30. Genetics of type 1 von Willebrand disease.
Goodeve A
Curr Opin Hematol; 2007 Sep; 14(5):444-9. PubMed ID: 17934350
[TBL] [Abstract][Full Text] [Related]
31. Two new candidate mutations in type IIA von Willebrand's disease (Arg834-->Gly, Gly846-->Arg) and one polymorphism (Tyr821-->Cys) in the A2 region of the von Willebrand factor.
Donnér M; Kristoffersson AC; Berntorp E; Scheibel E; Thorsen S; Dahlbäck B; Nilsson IM; Holmberg L
Eur J Haematol; 1993 Jul; 51(1):38-44. PubMed ID: 8348943
[TBL] [Abstract][Full Text] [Related]
32. [Detection of gene mutation and genetic analysis of a patient with type 3 von Willebrand disease].
Li Z; Wang Y; Wan H
Zhonghua Xue Ye Xue Za Zhi; 1998 Mar; 19(3):122-4. PubMed ID: 11243141
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of a novel mutation in von Willebrand factor causing type 2B von Willebrand's disease.
Facey DA; Favaloro EJ; Koutts J; Berndt MC; Hertzberg MS
Br J Haematol; 1999 May; 105(2):538-41. PubMed ID: 10233434
[TBL] [Abstract][Full Text] [Related]
34. The mutation spectrum associated with type 3 von Willebrand disease in a cohort of patients from the north west of England.
Sutherland MS; Keeney S; Bolton-Maggs PH; Hay CR; Will A; Cumming AM
Haemophilia; 2009 Sep; 15(5):1048-57. PubMed ID: 19601990
[TBL] [Abstract][Full Text] [Related]
35. Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1.
Schneppenheim R; Budde U; Krey S; Drewke E; Bergmann F; Lechler E; Oldenburg J; Schwaab R
Thromb Haemost; 1996 Oct; 76(4):598-602. PubMed ID: 8903002
[TBL] [Abstract][Full Text] [Related]
36. Ins405AsnPro mutation in the von Willebrand factor propeptide in recessive type 2A (IIC) von Willebrand's disease.
Holmberg L; Karpman D; Isaksson C; Kristoffersson AC; Lethagen S; Schneppenheim R
Thromb Haemost; 1998 Apr; 79(4):718-22. PubMed ID: 9569179
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis of subtype 2B von Willebrand disease in a patient with 2A phenotype of plasma von Willebrand factor.
Gaucher C; de Romeuf C; Rauïs-Morret M; Corazza F; Fondu P; Mazurier C
Thromb Haemost; 1995 Apr; 73(4):610-6. PubMed ID: 7495067
[TBL] [Abstract][Full Text] [Related]
38. Characterization of three mutations causing von Willebrand disease type IIA in five unrelated families.
Inbal A; Seligsohn U; Kornbrot N; Brenner B; Harrison P; Randi A; Rabinowitz I; Sadler JE
Thromb Haemost; 1992 Jun; 67(6):618-22. PubMed ID: 1324533
[TBL] [Abstract][Full Text] [Related]
39. Nonsense mutations of the von Willebrand factor gene in patients with von Willebrand disease type III and type I.
Zhang ZP; Lindstedt M; Falk G; Blombäck M; Egberg N; Anvret M
Am J Hum Genet; 1992 Oct; 51(4):850-8. PubMed ID: 1415226
[TBL] [Abstract][Full Text] [Related]
40. The international society on thrombosis and haematosis von Willebrand disease database: an update.
Hampshire DJ; Goodeve AC
Semin Thromb Hemost; 2011 Jul; 37(5):470-9. PubMed ID: 22102189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
